Telomerase activity, and tissue polypeptide specific antigen (TPS) in Egyptian breast cancer patients.

[1]  P. Drew,et al.  Genetic changes associated with telomerase activity in breast cancer , 1999, International journal of cancer.

[2]  R. Wurm,et al.  Telomere shortening triggers a p53-dependent cell cycle arrest via accumulation of G-rich single stranded DNA fragments , 1999, Oncogene.

[3]  S. Sukumar,et al.  Telomerase activity in ductal carcinoma in situ and invasive breast cancer , 1999, Oncogene.

[4]  K. Mokbel,et al.  Telomerase activity and prognosis in breast cancer. , 1999, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[5]  S. Sukumar,et al.  Applications of telomerase research in the fight against cancer. , 1999, Molecular medicine today.

[6]  C. Poremba,et al.  Telomerase activity in human proliferative breast lesions. , 1998, International journal of oncology.

[7]  B. Pogo,et al.  Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by 3'-azido-3'-deoxythymidine. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[8]  Z. Kopczyński,et al.  The value of tissue polypeptide specific antigen TPS determination in serum of women with breast cancer comparison to mucin-like associated antigen MCA and CA 15-3 antigen. , 1998, European journal of gynaecological oncology.

[9]  C. Osborne,et al.  Telomerase activity and survival of patients with node-positive breast cancer. , 1997, Journal of the National Cancer Institute.

[10]  E. Blackburn.  The telomere and telomerase: nucleic acid-protein complexes acting in a telomere homeostasis system. A review. , 1997, Biochemistry. Biokhimiia.

[11]  Nam W. Kim,et al.  Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP) , 1997, Nucleic Acids Res..

[12]  J. Shay,et al.  A survey of telomerase activity in human cancer. , 1997, European journal of cancer.

[13]  E. K. Parkinson,et al.  Amplification, increased dosage and in situ expression of the telomerase RNA gene in human cancer , 1997, Oncogene.

[14]  J. T. Lumeij,et al.  Avian Clinical Biochemistry , 1997 .

[15]  F. Ishikawa.  [Telomere and telomerase]. , 1996, Human Cell.

[16]  G. Eklund,et al.  Notable relationship between the level of tumor marker TPS in serum and survival in breast cancer. , 1996, Anticancer research.

[17]  J. Shay,et al.  Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. , 1995, Nucleic acids research.

[18]  T. Salman,et al.  The clinical value of serum TPS in gynecological malignancies , 1995, The International journal of biological markers.

[19]  C B Harley,et al.  Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.

[20]  Henderson Ar,et al.  Assessing test accuracy and its clinical consequences: a primer for receiver operating characteristic curve analysis. , 1993 .

[21]  Max H. Myers,et al.  Manual for Staging of Cancer , 1992 .

[22]  C B Harley,et al.  Telomere loss: mitotic clock or genetic time bomb? , 1991, Mutation research.

[23]  I. MartínezMartínez.  Epidemiology of Cancer , 1984 .

[24]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.